Literature DB >> 28695962

Gdf11/Smad signalling and Cdx proteins cooperate to activate the Hoxc8 early enhancer in HepG2 cells.

Stephen J Gaunt1.   

Abstract

Developing anatomy along the head-tail axis of bilaterian embryos is specified, to a large extent, by the overlapping patterns of expression of the Hox genes. Hox gene enhancers respond to a variety of signals in order to regulate these discreet domains of expression. For mouse Hoxc8, the 399bp "early enhancer" plays a major role. Activation of this enhancer is now examined using luciferase expression constructs transfected into HepG2 cells. Constructs are activated by the combined actions of Gdf11/Smad and Cdx protein signalling pathways, both of which are functional in early embryos. Each of these pathways alone has little stimulatory effect. Stimulation by the two pathways together exceeds the sum of the effects of each pathway alone, indicating synergistic activity. By mutation analysis, two Smad binding motifs are identified as mediators of the Gdf11 effect and two Cdx binding motifs mediate the Cdx effect. The two Smad motifs and one of the Cdx sites are conserved from fish to mammals. Gdf11 stimulation is partially inhibited by Specific Inhibitor of Smad3, suggesting that Smad3 plays a part in signal transduction. Fgf2 increases luciferase activation by the Hoxc8 enhancer, but not, apparently, by specific interactions with either Gdf11 or Cdx effects.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28695962     DOI: 10.1387/ijdb.170066sg

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  2 in total

1.  Bioinformatics network analyses of growth differentiation factor 11.

Authors:  Feng Zhang; Xia Yang; Zhijun Bao
Journal:  Open Life Sci       Date:  2022-04-26       Impact factor: 1.311

2.  GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy.

Authors:  Javier Duran; Mayarling Francisca Troncoso; Daniel Lagos; Sebastian Ramos; Gabriel Marin; Manuel Estrada
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.